Platelets (Megakaryocytes)

We are developing human platelets (Megakaryocytes) from human (non-embryo) induced pluripotent stem cells (iPSCs) in a two-step process (iPSCs to HSCs and HSCs to Megakaryocytes). Our novel protocols will use small molecules to make platelets, which will allow production of platelets at scale. We will use our platelets as the foundation for a cell therapy for the treatment of blood loss and various blood diseases and disorders, which we are developing.